Visualize New Stool Dna Diagnostic Detects 92.3% Of Colon Cancers | Quantified for Stool Dna Testing For Colorectal Cancer
Article Related to Stool Dna Testing For Colorectal Cancer :
Diagnose Colorectal Cancer or Colon Cancer – stool dna testing for colorectal cancer
Colorectal cancer, also known as CRC or colon cancer, is one of the leading cancers causing deaths in the U.S ., striking both men and women evenly. Beating both prostate cancer and breast cancer in mortality rate, colon cancer is second to lung cancer in causing death. With roughly 150,000 new cases diagnosed per year and approximately 60,000 deaths per year, the remarkable information is that colon cancer is exceedingly preventable. The reality is that when colon cancer is spied early, with care, the 5-year survival rate is more than 90%. This is why colon cancer screening is crucial to prevent and rapidly identify this deadly disease.
Colon Cancer Screening
The American Cancer Society recommended for both men and women should adopt one of the following 5 colon cancer screening recommendations, even if they are only at median probability for developing colon cancer.
* A yearly fecal magical blood experiment, also announced FOBT, or a fecal immunochemical experiment, too called FIT
* A flexible sigmoidoscopy assessment every 5 years
* A yearly fecal esoteric blood research( FOBT) or fecal immunochemical exam( FIT) including a resilient sigmoidoscopy every 5 years
* A doubled compare barium enema every 5 years
* A colonoscopy every 10 years
The most preferred option of all of these colon cancer screening recommendations is# 3: a yearly fecal magical blood exam( FOBT) or fecal immunochemical research( FIT) including a resilient sigmoidoscopy every 5 years. The American Cancer Society also recommends that all colon cancer screening experiments with positive results be immediately followed by a colonoscopy.
A New Home Colon Cancer Screening Kit
One of the most exciting the development in colon cancer screening is the development of a brand-new residence test announced Quidel’s QuickVue iFOB Test. This easy test is a type of fecal immunochemical evaluation( FIT) that a patient squanders at home. In the privacy rights of home, individual patients accumulates a test, ends the contents of the gear, and forwards a sample to a specified specialist or laboratory for testing. This simple home colon cancer screening test spies any blood in the sample, which indicates their own problems of gastrointestinal disorders like colon cancer.
Requiring only one specimen, the Quidel QuickVue iFOB Test spots human blood, or hemoglobin. Patients is not need to follow any dietary restrictions, however, there are a few restraints involving drugs. This distinguishes this home colon cancer screening assessment from guaiac located research with arduous restraints. The American Cancer Society recommends the Quidel QuickVue iFOB Test because it is patient friendly, resulting in more beings taking the test than with guaiac or FOBT evaluations. When the colon cancer screening process is simple, the hope is that more patients will make the test.
Unfortunately, even with the advancements in colon cancer screening, fewer than 50% of beings over persons under the age of 50 make the test on the recommended basis. Numerous beings over this age “ve never” even taken a colon cancer screening research. Education shall respond. If people knew that it could take 10 times for cancerous cadres to take over, they would realize that early detection through a colon cancer screening is an easy and painless action to save “peoples lives”